Company Filing History:
2 out of 5 
1 out of 1 
1 out of 8 Years Active: 2009
Title: Monica Borgatti: Innovator in Thalassemia Treatment
Introduction
Monica Borgatti is a notable inventor based in Ferrara, Italy. She has made significant contributions to the field of medicine, particularly in the treatment of thalassemia. With a total of 2 patents, her work focuses on innovative therapeutic approaches.
Latest Patents
Monica Borgatti's latest patents include the use of angelicin and its structural analogues for the treatment of thalassemia. This patent describes the preparation of a medicament for the therapeutic treatment of beta-thalassemia, with bergapten being a particularly preferred structural analogue. Another significant patent involves the use of rapamycin and its structural analogues for the same therapeutic purpose, highlighting her commitment to advancing treatment options for this condition.
Career Highlights
Throughout her career, Monica has worked with esteemed organizations such as Associazione Veneta Per La Lotta Alla Talassemia and Università degli Studi di Ferrara. Her dedication to research and innovation has positioned her as a key figure in the medical community.
Collaborations
Monica has collaborated with notable colleagues, including Nicoletta Bianchi and Roberto Gambari. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Monica Borgatti's innovative work in the treatment of thalassemia showcases her dedication to improving patient outcomes. Her patents reflect a commitment to advancing medical science and providing new hope for those affected by this condition.